Cannabinoids for Everyday Health

The BayMedica biosynthetic production method is designed to deliver natural cannabinoids like CBC, CBN and CBG that are identical to those found in hemp and cannabis.  Unlike “extracted” cannabinoids, BayMedica cannabinoids are “pharmaceutical-grade” because they are made and purified by a proprietary process that is the same each and every time. Our ProDiolTM cannabinoids will be available as bulk, GRAS certified, ingredients for use in a wide variety of consumer applications including nutraceuticals, cosmetics and animal-health. Combined with natural terpenes and phytonutrient-rich carrier oils, our cannabinoid solutions have synergistic properties that we call the Ensemble EffectTM. Our PureDiolTM line of ultra-rare and  novel cannabinoid analogs will be available for life science, biopharmaceutical, testing and research purposes.

.

.

prodiol

The BayMedica method is able to deliver natural cannabinoids like CBC, CBN and CBG that are identical to those found in hemp or marijuana, but through a clean, consistent and reliable method.

Our ProDiol cannabinoids are “pharmaceutical-grade”,  identical to the compound found in the plant, generally recognized as safe (GRAS). ProDiol cannabinoids can be custom formulated and will be sold directly to manufacturers that produce products for  variety of applications including supplements, nutraceuticals, functional food & beverages, cosmetics and animal-health.

purediol

The BayMedica platform is set to deliver ultra-rare and novel cannabinoids under our PureDiol product line.

Because we never touch the plant PureDiol products are guaranteed to be free of contaminants commonly found in products produced by traditional extraction methods.

PureDiol products are designed for use in life sciences, biopharmaceuticals, testing and research areas.

.

prodiolTM Cannabinoids

Cannabichromene

Cannabichromene (CBC) is non-intoxicating, non-psychoactive cannabinoid that is believed to function by binding the CB2 receptor as well as the vanilloid receptor 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1). The result of engaging these receptors is increased levels of natural endocannabinoids that are known to have positive effects on many body systems.

CBC has been shown to function in supporting:

  • Pain
  • Inflammation & Irritable Bowel Syndrome
  • Neuro-Protection
  • Skin Health
  • Mild Anxiety (10X greater than CBD)

Cannabinol

Cannabinol (CBN), is produced by the oxygenation and decomposition  of  THC. Unlike THC, CBN is  a non-intoxicating cannabinoid that produces pleiotropic effects through binding of various receptors including  the cannabinoid receptor 2(CB2) and vanilloid, TRPV2 receptor. Like other CB2 agonists, CBN is  believed to produce a number of positive effects by engaging the Endocannabinoid System.   

CBN has been shown to function in supporting:

  • Pain
  • Inflammation
  • Insomnia
  • Appetite 
  • Seizures

Cannabigerol

Cannabigerol (CBG), is non-intoxicating, non-psychoactive cannabinoid. As a precursor to CBC, CBD and THC, it is found in moderate quantities in the plant and is less well studied than CBD. However, studies to date indicate that like CBC and CBD, CBG acts through the engaging the cannabinoid 2 receptor and exerts its effects via the Endocannabinoid System.

CBG has been shown to function in supporting:

  • Glaucoma
  • Irritable Bowel Syndrome (IBS)
  • Neuro-Protection
  • Microbial Control
  • Appetite Stimulation

Discover the Future of Cannabinoids